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The carbohydrate chains of glycolipids and glycoproteins at the cell surface 
are known to undergo many rapid changes during embryogenesis. These devel- 
opmental  changes  include  (a)  alteration  of branching  structure  in  lactoseries 
carbohydrate  chains,  identified as  I/i  interconversion  (1),  (b)  modification of 
terminal  chains,  responsible  for  the  transition  from  Ii  to  ABH  or  SSEA-1 
(reviewed in  2),  (c) transition of globoseries antigen expression through pk,  p, 
and Forssman (3), and (d) switching of core structure synthesis from one series 
to another,  such as  SSEA-3 ÷ globoseries to SSEA-1 + lactoseries (4).  Although 
these  structural  changes  have  been  defined clearly using various  monoclonal 
antibodies, their physiological significance is unclear. 
The appearance  of SSEA-1  on the  embryo surface after the third  cleavage 
division correlates approximately in time with the onset of compaction (5). During 
compaction,  blastomeres  maximize their  intercellular contacts and  generate a 
polar  distribution  of microvilli (6).  Identification of SSEA-1  as  the  X  hapten 
(Gall31  ---* 4[Fucal  --0 3]GIcNAcI31  ~  R) (7-9) suggested the possibility of a  3- 
fucosyl-N-acetyllactosamine recognition system in the early mouse embryo. To 
test this hypothesis, we have studied the effect of lacto-N-fucopentaose III, its 
analogues, and their multivalent lysyllysine conjugates on compaction. 
Materials and Methods 
Purification of Oligosaccharides.  A mixture of lacto-N-fucopentaose (LNFP) I, II, and 
III was obtained from human milk by the method of Kobata (10).  LNFP I, II, and III 
(unreduced) were separated after acetylation by preparative thin-layer chromatography 
on HPTLC plates (J. T. Baker Chemical Co., Phiilipsburg, NJ) using a solvent system of 
butylacetate-acetone-water (25:8:1).  After deacetylation, purified pentasaccharides were 
lyophilized and stored at -20 ° C. Chitotriose (GlcNAcI31 --~ 3GlcNA031 ---, 3GIcNAc) was 
a gift from Professor Toshiaki Osawa, University of Tokyo. 
Covalent Attachment of Oligosaccharides to LysyUysine.  Purified oligosaccharides were 
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coupled  to lysyilysine by reductive amination  as described  previously by Schwartz and 
Gray (11). This method is based on the ability of cyanoborohydride to reduce a Schiff 
base selectively at pH > 5. Briefly, unreduced oligosaccharide, L-lysyilysine  2HC1 (Bachem 
Fine Chemicals, Torrance, CA), and sodium cyanoborohydride (Sigma Chemical Co., St. 
Louis, MO) were  mixed in  a  molar ratio of 0.35:0.033:1.00  and dissolved in 0.2  M 
potassium phosphate (pH 8.0). After 72 h at 37°C, the oligosaccharide-lysyllysine  conju- 
gate was separated  from free oligosaccharide, cyanoborohydride, and buffer salts by P2 
molecular sieve chromatography. Oligosaccharide-lysyllysine conjugates eluted immedi- 
ately after the void volume and were identified routinely in a spot test using 0.5% orcinol 
in a 10% H2SO4 spray. 
Preimplantation Embryo Culture and Compaction Assays.  4-8-celi embryos were flushed 
from the oviducts of Swiss Webster mice (Tyler Labs, Seattle, WA) on day 3 postcoitum. 
These precompaction  embryos were cultured overnight to obtain a homogeneous popu- 
lation of fully compacted 8-16-cell morulae. Embryos were cultured in Whitten's medium 
under mineral oil on 50-ram petri dishes (Falcon Labware, Oxnard, CA) at 37°C in a 5% 
CO2-in-air humidified incubator. On the morning of day 4, compacted 8-16-cell embryos 
were transferred briefly into Tyrode's salt solution containing 0.4% polyvinylpyrrolidone 
(pH  2.5) to remove zonae pellucidae.  For compaction  assays, zona-free embryos  were 
transferred into 60-t~l droplets of Whitten's medium containing various oligosaccharides 
or their conjugates with lysyllysine  and were cultured under oil at 37°C.  Stock solutions 
of the oligosaccharide-lysyllysine conjugates (2 mM each) and the free oligosaccharides 
(20 mM each) were prepared in Whitten's medium, passed through a 0.22 #m filter, and 
stored at 4 °  C. Effects on compaction were photographed using a Polaroid camera attached 
to a  Nikon  inverted phase  microscope.  Embryos were  scored  as compaction  reversed 
(decompacted) if three or more blastomeres were not in close apposition. 
Results 
Lacto-N-fucopentaose I (H hapten), II (Le  a hapten), and III (X hapten) were 
isolated from human milk. The purity and chemical structure of these pentasac- 
charides are  shown in  Fig.  1,A  and B.  Multivalent haptens were obtained by 
coupling LNFP II, LNFP III, and chitotriose to the primary amino groups of 
iysyllysine. Purified oligosaccharide-lysyllysine  conjugates were not reacuve with 
fluorescamine or ninhydrin, indicating the absence of any primary amino group 
and suggesting, therefore, the presence of 3 moles of oligosaccharide per mole 
of lysyllysine. The  predicted  chemical  structure  of the  LNFP  III-lysyllysine 
conjugate is shown in Fig. 1 C. 
LNFP II and III and their multivalent lysyllysine conjugates were tested for 
possible inhibitory effects on compaction of the early mouse embryo. As shown 
in Fig. 2D, the multivalent LNFP III-lysyllysine  conjugate had a dramatic effect 
on cultures of fully compacted 8-16-cell embryos: individual blastomeres were 
observed to  round up  and  lose  their close apposition of membranes.  Similar 
results were obtained in five separate experiments. This decompaction phenom- 
enon was not observed in cultures of embryos treated with the multivalent LNFP 
II-lysyllysine or chitotriose-lysyllysine  conjugates (Fig. 2, C and E, respectively). 
Furthermore, decompaction was not observed in cultures of embryos treated 
with a mixture of LNFP III (unconjugated) plus lysyllysine (Fig. 2F), suggesting 
the critical importance of X hapten valency. 
The effect of LNFP III-lysyllysine concentration and the time of incubation 
on compaction are  shown  in  Fig.  3.  LNFP III-lysyllysine caused embryos to 
decompact at concentrations between 0.125 and 1 raM, while LNFP III (uncon- 
jugated) had no effect at concentrations as high as 5 mM (Fig. 3A).  The effect FENDERSON  ET  AL.  BRIEF  DEFINITIVE  REPORT  1593 
FIGURE  1.  Thin-layer chromatography  of unreduced, acetylated pentasaccharides in bu- 
tylacetate-acetone-water (25:8:1), revealed by 0.5% orcinol in 10% H~SO4 (A). LNFP III (lane 
a),  I1 (b), and I  (c) were purified from  the original mixture as described in Materials and 
Methods.  The  chemical  structure  of these  purified  pentasaccharides  is shown  in B.  The 
chemical structure of the LNFP IIl-lysyUysine  conjugate is shown in C (GIc-CH** represents 
a  1-deoxy-D-glucosyl  residue without pyranose ring). 
of LNFP III-lysyllysine on compaction was not immediate, requiring 6-8  h  of 
culture  (Fig.  3B).  Decompacted  embryos were  fully viable,  as  determined by 
trypan  blue exclusion.  After  12  h  of culture,  however,  the dramatic  effect of 
LNFP III-lysyllysine on early embryo development was irreversible and blasto- 
cyst formation was prevented.  LNFP III-lysyllysine had no effect on the mor- 
phology of blastocyst-stage embryos. 
Discussion 
Compaction is the first of many specific cell-cell interactions occurring rapidly 
during mafilmalian embryogenesis. Previous studies have shown that compaction 
requires  Ca  ++ (12)  and N-linked  glycoconjugate biosynthesis (13).  A  Ca++-de  - 
pendent  cell  adhesion  molecule has  been  identified  that  apparently  mediates 
interblastomere adhesion during compaction (14,  15). Recently (16), a monoclo- 
nal antibody directed to this  124,000  mol wt glycoprotein has  been  found to 
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FIGURE 2.  8-16-cell compacted embryos (a) were cultured in Whitten's medium alone (b) or 
in  Whitten's  medium  containing  either  1 mM  LNFP II-lysyllysine (c), 1 mM  LNFP  III- 
lysyllysine (d), 1 mM chitotriose-lysyllysine  (e), or 5 mM LNFP III (unconjugated) plus 1 mM 
lysyllysine (f). Embryos are shown after 8-12 h (c-f) or 24 h (b) of culture. X 150. 
The  results  presented  here  suggest  that  a  multivalent  X  hapten  recognition 
system  may contribute  also  to  the  process  of compaction.  Such  a  recognition 
system might involve a cell surface iectin, glycosyl transferase, or glycosyl hydro- 
lase in  a  lock-and-key mechanism.  Alternatively,  the  X  hapten  structure  might 
regulate  certain  membrane  proteins,  including  the  124,000  tool  wt  Ca÷+-de  - 
pendent  cell  adhesion  molecule.  Models  of specific carbohydrate-carbohydrate 
interaction through hydrogen bonding can also be envisioned. FENDERSON  ET  AL.  BRIEF  DEFINITIVE  REPORT  1595 
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FIGURE 3.  Dose response (A) and time course (B) for decompaction by the multivalent LNFP 
III-lysyllysine  conjugate. 8-16-cell compacted embryos (15-60 per group) were cultured in 
the presence of LNFP III-lysyllysine  (O), LNFP II-lysyllysine  (m), chitotriose-lysyllysine  (A), 
or LNFP III (5 mM, unconjugated) plus 1 mM lysyllysine (O). The percentage of decompacted 
embryos was  scored after  10-12  h  of culture (A) or  scored  hourly  for  10  h  (B). The 
concentration of oligosaccharide-lysyllysine  conjugates used in the time course assay (B) was 1 
mM. Similar results were obtained in replicate assays. 
The fact that a multivalent LNFP III hapten was able to decompact embryos, 
whereas free oligosaccharide was ineffective (Figs. 2 and 3), suggests the critical 
importance of X hapten valency. Carbohydrate recognition in other biological 
systems has been shown to require a high density or "clustering" of sugar residues 
(17). Thus, it may be significant that the X hapten is apparently carried by the 
early mouse embryo on a  highly branched lactosaminoglycan (embryoglycan) 
(reviewed in  18). Embryoglycan purified from F9 embryonal carcinoma cells, 
however, did  not  decompact embryos;  instead,  it  caused rapid  agglutination 
(unpublished observations). Thus, the decompaction phenomenon appears to be 
associated with  lower molecular weight compounds.  The  limits of molecular 
weight and valency required for decompaction versus agglutination remain to 
be studied. Multivalent oligosaccharide-lysyilysine  conjugates should prove useful 
for future studies on the functional role of cell surface carbohydrates in cell-cell 
interactions. 
Summary 
A multivalent lacto-N-fucopentaose (LNFP) III-lysyllysine conjugate was ob- 
served to decompact preimplantation mouse embryos.  Decompaction was not 
obtained  with  free oligosaccharides (LNFP  II and  III), nor with multivalent 
LNFP II-lysyllysine or chitotriose-lysyllysine conjugates. These results suggest a 
role for X  hapten recognition during compaction and suggest further that X 
hapten valency may play a key role in modulating this developmental process. 
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